Immunization with a pentameric L1 fusion protein protects against papillomavirus infection

Journal of Virology

Volumn 75, Issue 17, 2001, Pages 7848-7853

  Yuan, H ^a   Eestes, P A ^a   Chen, Y ^a   Newsome, J ^a   Olcese, V A ^a   Garcea, R L ^a   Schlegel, R ^a  

^a GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CAPSID PROTEIN; GLUTATHIONE TRANSFERASE; HYBRID PROTEIN; VIRUS VACCINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; ESCHERICHIA COLI; IMMUNIZATION; IMMUNOGENICITY; NONHUMAN; PAPILLOMA; PAPILLOMA VIRUS; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN EXPRESSION; VIRUS CAPSID; VIRUS PARTICLE;

ANIMALS; ANTIBODIES, VIRAL; CAPSID; DISEASE MODELS, ANIMAL; DOGS; ESCHERICHIA COLI; GLUTATHIONE TRANSFERASE; HUMANS; MOUTH; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PROTEIN CONFORMATION; RECOMBINANT FUSION PROTEINS; TUMOR VIRUS INFECTIONS; VACCINATION; VACCINES, SYNTHETIC; VIRAL VACCINES;

EID: 0034872411     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.75.17.7848-7853.2001     Document Type: Article

References (30)

1. Expression of human papillomavirus type 6 and type 16 capsid proteins in bacteria and their antigenic characterization
2. A formalin-inactivated vaccine protects against mucosal papillomavirus infection: A canine model
3. Two antibodies that neutralize papillomavirus by different mechanisms show distinct binding patterns at 13 A resolution
4. Human papillomavirus vaccines
5. Immunization with viruslike particles from cottontail rabbit papillomavirus (CRPV) can protect against experimental CRPV infection
6. Structure of small virus-like particles assembled from the L1 protein of human papillomavirus 16
7. Mutant canine oral papillomavirus L1 capsid proteins which form virus-like particles but lack native conformational epitopes
8. Immunization with viruslike particles induces long-term protection of rabbits against challenge with cottontail rabbit papillomavirus
9. Identification of proteins encoded by the L1 and L2 open reading frames of human papillomavirus 1a
10. Comparison of neutralization of BPV-1 infection of C127 cells and bovine fetal skin xenografts
11. Self-assembly of human papillomavirus type 1 capsids by expression of the L1 protein alone or by coexpression of the L1 and L2 capsid proteins
12. Sequence determination of human papillomavirus type 6a and assembly of virus-like particles in Saccharomyces cerevisiae
13. Identification of immunoreactive antigens of human papillomavirus type 6b by using Escherichia coli-expressed fusion proteins
14. Papillomavirus L1 major capsid protein self-assembles into virus-like particles that are highly immunogenic
15. Virus-like particles of bovine papillomavirus type 4 in prophylactic and therapeutic immunization
16. Interim guidelines for management of abnormal cervical cytology
17. Expression of the human papillomavirus type 11 L1 capsid protein in Escherichia coli: Characterization of protein domains involved in DNA binding and capsid assembly
18. Progression from papilloma to carcinoma is accompanied by changes in antibody response to papillomavirus proteins
19. The immunology of animal papillomaviruses
20. Human papillomavirus type 11 recombinant L1 capsomeres induce virusneutralizing antibodies
21. Self-assembly of purified polyomavirus capsid protein VP1
22. Synthesis and assembly of virus-like particles of human papillomaviruses type 6 and type 16 in fission yeast Schizosaccharomyces pombe
23. Papillomavirus-like particles and HPV vaccine development
24. Humoral assays of human sera to disrupted and nondisrupted epitopes of human papillomavirus type 1
25. Mucosotropic papillomavirus infections
26. Systemic immunization with papillomavirus L1 protein completely prevents the development of viral mucosal papillomas
27. Expression of human papillomavirus type 6 E1, E2, L1 and L2 open reading frames in Escherichia coli
28. Expression of human papillomavirus type 16 L1 protein in Escherichia coli: Denaturation, renaturation, and self-assembly of virus-like particles in vitro
29. Viruses in human cancers